LFST Stock Analysis: Buy, Sell, or Hold?
LFST - LifeStance Health Group, Inc. Common Stock
$7.50
-0.26 (-3.35%)
▼
5d:
-1.45%
30d:
+3.16%
90d:
+2.32%
BUY
MODERATE Confidence
Analysis Updated: Jun 3, 2026 12:00 AM ET
Earnings: Aug 06, 2026
Get Alerted When LFST Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: LFST shows positive signals but monitor for confirmation. Market pricing in 6.1% decline. Moderate conviction.
💡 BUY OPPORTUNITY: LFST shows positive signals but monitor for confirmation. Market pricing in 6.1% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$17.63
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$10.95
31.5% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 22.9x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: LFST is currently trading at $7.50, which is considered slightly low relative to its 30-day fair value range of $7.36 to $7.98. From a valuation perspective, the stock is trading at a discount (Forward PE: 19.0) compared to its historical average (22.9). Remarkably, the market is currently pricing in an annual earnings decline of 6.1% over the next few years. This pessimistic expectation contrasts with the company's recent 1927.5% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, LFST is in a downtrend. Immediate support is located at $7.24, while resistance sits at $7.98. Short-term momentum is weak, with the stock down 3.4% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $10.72 (+43.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, LFST is in a downtrend. Immediate support is located at $7.24, while resistance sits at $7.98. Short-term momentum is weak, with the stock down 3.4% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $10.72 (+43.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$7.36 -
$7.98
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.8%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.4%)
- BULLISH: Trading 43.0% below Wall St target ($10.72)
Trading Range Analysis
30-Day Trading Range
$7.36 -
$7.98
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$7.24
Resistance Level
$7.98
Current Trend
Downtrend
Technical data as of
Jun 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
18.97
Wall Street Target
$10.72
(+43.0%)
Revenue Growth (YoY)
21.2%
Earnings Growth (YoY)
1927.5%
Profit Margin
1.6%
Valuation Discount vs History
-6.1% cheaper
PE vs Historical
19.0 vs 22.9
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-6.1%
(market-implied from PE analysis)
1-Year Target
$7.04
(-6%)
2-Year Target
$6.61
(-12%)
3-Year Target
$6.21
(-17%)
3-Yr Target (if PE normalizes)
(PE: 19→23)
$7.49
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.9, Growth: 25.3%)
$17.05
(+127%)
Base:
(SPY PE: 19.0, Growth: 25.3%)
$14.77
(+97%)
Bear:
(PE: 16.1, Growth: 25.3%)
$12.55
(+67%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (51x PE), but valuation improves significantly next year (19x PE) as earnings recover.
Forward PE: 50.76 | Forward EPS (Implied): $0.15
Bull Case
$9.43
(+21%)
Analyst growth 15.0%, PE expands to 53.3
Base Case
$7.81
(0%)
Market implied 0.0%, PE stable at 50.8
Bear Case
$5.97
(-24%)
Severe decline -15.0%, PE contracts to 45.7
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 19.0 to 22.9
Stabilization Target:
$9.05
(+20.7%)
PE Expansion Potential:
+20.7%
Share & Embed Analysis
Last updated: June 03, 2026 7:27 PM ET
Data refreshes hourly during market hours. Next update: 8:27 PM
Data refreshes hourly during market hours. Next update: 8:27 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LFST showing a specific setup today?
Insider Activity (6 Months)
0
Buys
8
Sells
Net
INSIDERS SELLING
Recent Transactions
Robert Bessler
SELL
5101 shares
2026-04-21
Darren M Black
SELL
4314939 shares
2026-03-02
Robert Bessler
SELL
1701 shares
2025-12-22
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$245 | 50 HOLD |
|
HCA
HCA Healthcare, Inc. |
BUY
25 analysts |
$511 | 55 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$22 | 67 BUY |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$142 | 56 HOLD |
|
ADUS
Addus HomeCare Corporati… |
STRONG BUY
11 analysts |
$133 | 55 HOLD |
